Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2025-12-25 @ 1:56 PM
NCT ID: NCT01943292
Description: The systematic method was through regular investigator assessment and regular laboratory testing.
Frequency Threshold: 0
Time Frame: Treatment Emergent Adverse Events (TEAEs) include all events (related and unrelated) from the time patient doses through 30 days post last dose of study treatment
Study: NCT01943292
Study Brief: Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Defactinib 200 mg Bid 200 mg po bid defactinib None None 0 3 3 3 View
Defactinib 400 mg Bid 400 mg po bid defactinib None None 0 3 3 3 View
Defactinib 600 mg Bid 600 mg po bid defactinib None None 0 3 3 3 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Blood Bilirubin Increased SYSTEMATIC_ASSESSMENT Investigations MedDra 16.0 View
Aspartate Aminotransferase Increased SYSTEMATIC_ASSESSMENT Investigations MedDra 16.0 View
Blood Alkaline Phosphatase Increased SYSTEMATIC_ASSESSMENT Investigations MedDra 16.0 View
Decreased Appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDra 16.0 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDra 16.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDra 16.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDra 16.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDra 16.0 View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDra 16.0 View
Cancer Pain SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDra 16.0 View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDra 16.0 View
Abdominal Distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDra 16.0 View
Abdominal Pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDra 16.0 View
Stomatitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDra 16.0 View
Oedema Peripheral SYSTEMATIC_ASSESSMENT General disorders MedDra 16.0 View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDra 16.0 View
Lower Limb Fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDra 16.0 View
Alanine Aminotransferase Increased SYSTEMATIC_ASSESSMENT Investigations MedDra 16.0 View
Blood Creatinine Increased SYSTEMATIC_ASSESSMENT Investigations MedDra 16.0 View
Blood Phosphorus Increased SYSTEMATIC_ASSESSMENT Investigations MedDra 16.0 View
Blood Pressure Increased SYSTEMATIC_ASSESSMENT Investigations MedDra 16.0 View
Hyperkalaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDra 16.0 View
Hyperuricaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDra 16.0 View
Hypouricaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDra 16.0 View
Pain in Extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDra 16.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDra 16.0 View
Peripheral Sensory Neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDra 16.0 View
Proteinuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDra 16.0 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDra 16.0 View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDra 16.0 View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDra 16.0 View
Dermatitis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDra 16.0 View
Pain of Skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDra 16.0 View